Small Interfering RNA (siRNA) Therapeutics Market in United States, United Kingdom– Market Outlook, Unmet Needs, Market Assessment & Forecast (2023-2030)

Small Interfering RNA (siRNA) Therapeutics Market – Report Overview

Pacific Business Consulting’s “Small Interfering RNA (siRNA) Therapeutics Market in 10MM – Market Outlook, Unmet Needs, Market Assessment & Forecast (2023-2030)” report offers a comprehensive understanding of Small Interfering RNA (siRNA) Therapeutics market, encompassing historical and projected market size data, along with market trends, market drivers, market barriers and unmet medical needs in the Ten Major Markets (10MM) of the United States, Germany, Spain, Italy, France, the United Kingdom, Japan, China, Australia, and India.

In 2022, the Small Interfering RNA (siRNA) Therapeutics market exceeded a valuation of over US$ 22.0 Billion, and it is poised for substantial growth, with a projected Compound Annual Growth Rate (CAGR) exceeding 8.0% from 2023 to 2030. The market is expected to potentially surpass US$ 35.0 Billion by 2030.

Small Interfering RNAs, or silencing RNA, represent a class of double-stranded non-coding RNA molecules with widespread applications in targeted gene silencing. These molecules play a crucial role in regulating gene expression, and their ability to selectively silence specific genes by disrupting the translation of their genetic code into proteins has made them a powerful tool in modern medicine and biotechnology.

siRNA is a key component of the RNA interference (RNAi) pathway, functioning to selectively turn off the expression of specific genes. It has broad applications in studying cellular phenotypes, such as cytokinesis, apoptosis, insulin signaling, and cell differentiation. The high potential of siRNA in gene silencing has led to its use in therapeutic applications, particularly in validating targets for diseases like cancer, HIV infection, and hepatitis.

The use of siRNA in research and development is supported by factors such as the rising number of clinical trials, short duration of pre-clinical development, increasing government funding for research, and a well-established healthcare infrastructure. siRNA’s ability to selectively and precisely target specific genes makes it a powerful tool for studying gene function and regulation, investigating diseases, and advancing personalized medicine.

In siRNA therapy, liposome-based systemic therapy and nanoparticle-based systemic therapy are common approaches. Liposome-based systems are associated with liver-targeted pharmacokinetics, limiting the therapeutic potential of siRNA therapy to liver diseases such as hepatocellular carcinoma, hepatitis, and hypercholesterolemia. Despite these limitations, siRNAs emerge as significant advancements in cancer therapy, playing a major role in regulating gene expression through RNA interference (RNAi).

Leading players in the Small Interfering RNA (siRNA) Therapeutics segment, including Alnylam Pharmaceuticals, Inc., Phio Pharmaceuticals (formerly known as RXi Pharmaceuticals), Arbutus Biopharma, Arrowhead Research Corp, Sanofi Genzyme, Genecon Biotechnologies Co., Ltd., Arbutus Biopharma Corp, and Silence Therapeutics AG, are expected to play a crucial role in shaping the future landscape of siRNA Therapeutics technologies through ongoing innovation.

Scope of Report

The report addresses critical subjects such as strategic competitor evaluation, market characterization, unmet needs, and the consequences of these elements for the Small Interfering RNA (siRNA) Therapeutics market. It also delves into the analysis of present and prospective market competition within the global Small Interfering RNA (siRNA) Therapeutics market.

Furthermore, the report offers an insightful examination of the primary industry drivers, constraints, and challenges. Each trend undergoes independent research to furnish qualitative analysis regarding its implications.

Reasons to Buy

• Develop your business strategies by gaining insights into the trends that shape and drive the Small Interfering RNA (siRNA) Therapeutics market across the 10MM (Ten Major Markets).
• Increase revenue by comprehending key trends, innovative products and technologies, market segments, and companies poised to influence the future of the 10MM Small Interfering RNA (siRNA) Therapeutics market.
• Craft effective sales and marketing strategies by thoroughly understanding the competitive landscape and analyzing the performance of various competitors.
• Identify emerging players with potentially robust product portfolios and devise strategic counter-strategies to gain a competitive advantage.
• Optimize your sales and marketing efforts by pinpointing market categories and segments that offer the greatest opportunities for consolidations, investments, and strategic partnerships.

1. Executive Summary: Small Interfering RNA (siRNA) Therapeutics
   • Global Market Outlook: Small Interfering RNA (siRNA) Therapeutics
2. Competitive Intelligence Analysis: Small Interfering RNA (siRNA) Therapeutics
3. Therapeutic Sector SWOT
4. Technology Roadmap Analysis: Small Interfering RNA (siRNA) Therapeutics
5. Market Background
   • Drivers
   • Restraints
   • Opportunity
   • Key Market Trends
   • Key Unmet Needs
6. Key Marketed Products Profile – Major Approved Products: Small Interfering RNA (siRNA) Therapeutics
   • Product Profile
   • Safety and Efficacy
7. Regulatory Landscape
8. Small Interfering RNA (siRNA) Therapeutics: Ten Major Market (10MM) – Market Analysis, By Product Type
   • Liposome Based Systemic Therapy
   • Nanoparticle Based Systemic Therapy
9. Small Interfering RNA (siRNA) Therapeutics: Ten Major Market (10MM) – Market Analysis, By Application
   • Cancer Treatment
   • Genetic Disorders
   • Neurological Disorders
   • Viral Infections
   • Others
10. Small Interfering RNA (siRNA) Therapeutics: Ten Major Market (10MM) – Market Analysis, By End User
    • Academic & Research Institutes
    • Pharmaceutical & Biotechnology Companies
11. Small Interfering RNA (siRNA) Therapeutics: Ten Major Market (10MM) – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Product Type
      • By Application
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Product Type
      • By Application
      • By End User

12. S. Small Interfering RNA (siRNA) Therapeutics – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Product Type
      • By Application
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Product Type
      • By Application
      • By End User

13. K. Small Interfering RNA (siRNA) Therapeutics – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Product Type
      • By Application
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Product Type
      • By Application
      • By End User

14. Germany Small Interfering RNA (siRNA) Therapeutics – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Product Type
      • By Application
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Product Type
      • By Application
      • By End User

15. France Small Interfering RNA (siRNA) Therapeutics – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Product Type
      • By Application
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Product Type
      • By Application
      • By End User

16. Italy Small Interfering RNA (siRNA) Therapeutics – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Product Type
      • By Application
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Product Type
      • By Application
      • By End User

17. Spain Small Interfering RNA (siRNA) Therapeutics – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Product Type
      • By Application
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Product Type
      • By Application
      • By End User

18. Japan Small Interfering RNA (siRNA) Therapeutics – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Product Type
      • By Application
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Product Type
      • By Application
      • By End User

19. China Small Interfering RNA (siRNA) Therapeutics – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Product Type
      • By Application
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Product Type
      • By Application
      • By End User

20. Australia Small Interfering RNA (siRNA) Therapeutics – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Product Type
      • By Application
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Product Type
      • By Application
      • By End User

21. India Small Interfering RNA (siRNA) Therapeutics – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Product Type
      • By Application
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Product Type
      • By Application
      • By End User

22. Competitive Landscape
    • Company Overview
    • Product Portfolio
    • Key Financials
    • Sales Footprint

Note – All Major Company Profiles (Count up to 20) will be covered in the report

23. Assumptions and Acronyms Used
24. Research Methodology
    • Secondary Research
    • Primary Research
    • Data Triangulation
25. Geographic Scope
    • The U.S., The U.K., Germany, France, Italy, Spain, Japan, China, Australia, and India
26. Copyrights and Disclaimer